Envestnet Portfolio Solutions Inc. Acquires 263 Shares of Balchem Co. (NASDAQ:BCPC)

Envestnet Portfolio Solutions Inc. raised its holdings in Balchem Co. (NASDAQ:BCPC) by 6.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,402 shares of the basic materials company’s stock after purchasing an additional 263 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Balchem were worth $717,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. FMR LLC lifted its stake in Balchem by 944.3% in the third quarter. FMR LLC now owns 497,495 shares of the basic materials company’s stock valued at $87,559,000 after purchasing an additional 449,854 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in shares of Balchem during the 4th quarter valued at $23,628,000. Raymond James Financial Inc. bought a new position in shares of Balchem during the 4th quarter worth $13,359,000. Barclays PLC increased its holdings in Balchem by 405.8% in the 3rd quarter. Barclays PLC now owns 60,777 shares of the basic materials company’s stock worth $10,695,000 after acquiring an additional 48,762 shares during the last quarter. Finally, Geneva Capital Management LLC raised its stake in Balchem by 5.1% in the 4th quarter. Geneva Capital Management LLC now owns 819,746 shares of the basic materials company’s stock valued at $133,615,000 after acquiring an additional 39,877 shares during the period. 87.91% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. StockNews.com downgraded shares of Balchem from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th. HC Wainwright reiterated a “buy” rating and issued a $190.00 price objective on shares of Balchem in a research note on Monday, February 24th. Finally, Sidoti raised shares of Balchem to a “hold” rating in a report on Tuesday, February 25th.

Balchem Trading Up 2.1 %

Shares of BCPC opened at $164.52 on Tuesday. Balchem Co. has a twelve month low of $137.69 and a twelve month high of $186.03. The stock has a market cap of $5.35 billion, a PE ratio of 41.86, a P/E/G ratio of 4.41 and a beta of 0.63. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The business’s 50-day moving average price is $164.88 and its 200-day moving average price is $169.34.

Balchem (NASDAQ:BCPC) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). The firm had revenue of $240.00 million for the quarter, compared to the consensus estimate of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. On average, equities analysts forecast that Balchem Co. will post 4.64 EPS for the current fiscal year.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.